Protagonist Therapeutics Inc (PTGX)
Protagonist Therapeutics Inc (PTGX)
Protagonist Therapeutics Inc (PTGX)
Penumbra Inc (PEN)
MacroGenics Inc (MGNX)
Coya Therapeutics Inc (COYA)
Coya Therapeutics Inc (COYA)
Coya Therapeutics Inc (COYA)
Coya Therapeutics Inc (COYA)
HUTCHMED DRC (HCM)
[Press Release] HUTCHMED Announces Positive Topline Results of Phase III Part of ESLIM-02 Trial of Sovleplenib for wAIHA in China